| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -43% |
| 3Y CAGR | +33% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -75% |
| 3Y CAGR | +123% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,799.30 -29.80 (0.62%) | 22,087.92 | 30.04 | 5.26 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,529.70 +7.70 (0.31%) | 19,159.13 | 28.26 | 5.34 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,645.00 +4.50 (0.06%) | 19,072.13 | 112.44 | 21.85 | ||
Marksans PharmaMARKSANS | ₹326.50 -4.95 (1.49%) | 15,029.18 | 28.84 | 4.97 |